Back
Viking Therapeutics Stock Predictions
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Buy
53
VKTX
Viking Therapeutics
Last Price:
64.14
Seasonality Move:
34.33%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Viking Therapeutics Stock Forecast
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 151.9% based on the past 9 years of stock performance.
- Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Viking Therapeutics Stock Undervalued?
The current Viking Therapeutics [VKTX] share price is $64.69. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal. - VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 151.9% based on the past 9 years of stock performance.
Viking Therapeutics Stock Rating
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics overpriced?
- Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
99.41
52-Week Low:
8.28
Prediction Charts
Market Cap:
7.17B
Price in USD:
64.69
Volume:
1.68M
Beta:
1.33
Technical Analysis
SMA50:
60.48
SMA100:
58.98
SMA200:
54.57
52-Wk Change:
495.12%
Stock Predictions
-
Is Viking Therapeutics stock public?
Yes, Viking Therapeutics is a publicly traded company. -
What is the Viking Therapeutics stock quote today?
The Viking Therapeutics stock price is 64.69 USD today. -
How to buy Viking Therapeutics stock online?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-13 | 63.08 | 66.73 | 67.94 | 62.63 |
| Sep-16 | 66.21 | 67.10 | 68.83 | 64.54 |
| Sep-17 | 66.12 | 62.94 | 67.06 | 62.20 |
| Sep-18 | 63.05 | 64.46 | 66.05 | 62.62 |
| Sep-19 | 66.27 | 68.19 | 68.20 | 65.18 |
| Sep-20 | 69.50 | 70.54 | 72.36 | 68.51 |
| Sep-23 | 70.64 | 65.01 | 70.64 | 64.61 |
| Sep-24 | 64.64 | 61.94 | 64.83 | 61.59 |
| Sep-25 | 62.69 | 63.13 | 65.61 | 62.23 |
| Sep-26 | 63.13 | 62.36 | 63.99 | 61.39 |
| Sep-27 | 62.51 | 61.63 | 63.22 | 61.29 |
| Sep-30 | 61.90 | 63.38 | 64.55 | 61.41 |
| Oct-1 | 63.22 | 62.00 | 63.78 | 60.57 |
| Oct-2 | 62.00 | 64.69 | 64.85 | 61.18 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.